nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CES1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00606	0.0956	CbGpPWpGaD
Capecitabine—DPYD—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00547	0.0863	CbGpPWpGaD
Capecitabine—CDA—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00487	0.0769	CbGpPWpGaD
Capecitabine—TYMP—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0039	0.0615	CbGpPWpGaD
Capecitabine—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.00248	0.134	CbGdCrCtD
Capecitabine—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.00248	0.134	CbGdCrCtD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00224	0.0354	CbGpPWpGaD
Capecitabine—TYMS—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00199	0.0314	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—CDKN2A—peripheral nervous system neoplasm	0.00192	0.0303	CbGpPWpGaD
Capecitabine—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.00188	0.102	CbGdCrCtD
Capecitabine—TYMP—Bladder Cancer—ERBB2—peripheral nervous system neoplasm	0.00183	0.029	CbGpPWpGaD
Capecitabine—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00174	0.0937	CbGdCrCtD
Capecitabine—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.0937	CbGdCrCtD
Capecitabine—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00174	0.0937	CbGdCrCtD
Capecitabine—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.0937	CbGdCrCtD
Capecitabine—DPYD—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00143	0.0225	CbGpPWpGaD
Capecitabine—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.071	CbGdCrCtD
Capecitabine—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.071	CbGdCrCtD
Capecitabine—TYMP—Bladder Cancer—MYC—peripheral nervous system neoplasm	0.0013	0.0205	CbGpPWpGaD
Capecitabine—CDA—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00127	0.02	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—TP53—peripheral nervous system neoplasm	0.00107	0.0168	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00106	0.0167	CbGpPWpGaD
Capecitabine—TYMP—Bladder Cancer—HRAS—peripheral nervous system neoplasm	0.00102	0.0161	CbGpPWpGaD
Capecitabine—TYMP—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00102	0.016	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000973	0.0154	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000945	0.0149	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000886	0.014	CbGpPWpGaD
Capecitabine—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00078	0.0421	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00078	0.0421	CbGdCrCtD
Capecitabine—TYMP—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000756	0.0119	CbGpPWpGaD
Capecitabine—CES1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000749	0.0118	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000717	0.0113	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000713	0.0112	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000679	0.0107	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000639	0.0101	CbGpPWpGaD
Capecitabine—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000537	0.029	CbGdCrCtD
Capecitabine—TYMS—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00052	0.0082	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GNS—peripheral nervous system neoplasm	0.000518	0.00818	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000511	0.00806	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NME1—peripheral nervous system neoplasm	0.000497	0.00784	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000495	0.00781	CbGpPWpGaD
Capecitabine—CES1—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000483	0.00762	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—COX2—peripheral nervous system neoplasm	0.000478	0.00754	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000477	0.00753	CbGpPWpGaD
Capecitabine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000471	0.00744	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000469	0.0074	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNS—peripheral nervous system neoplasm	0.000462	0.00729	CbGpPWpGaD
Capecitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000449	0.00708	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NME1—peripheral nervous system neoplasm	0.000443	0.00699	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000435	0.00686	CbGpPWpGaD
Capecitabine—CDA—Metabolism—COX2—peripheral nervous system neoplasm	0.000426	0.00672	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000417	0.00659	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000398	0.00628	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000391	0.00618	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000387	0.0061	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GNS—peripheral nervous system neoplasm	0.000369	0.00583	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NME1—peripheral nervous system neoplasm	0.000354	0.00558	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—COX2—peripheral nervous system neoplasm	0.000341	0.00538	CbGpPWpGaD
Capecitabine—TYMS—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000335	0.00529	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ENO2—peripheral nervous system neoplasm	0.000314	0.00495	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000302	0.00477	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000291	0.0046	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ENO2—peripheral nervous system neoplasm	0.00028	0.00441	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—BCHE—peripheral nervous system neoplasm	0.000265	0.00418	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000261	0.00412	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000258	0.00407	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000253	0.00399	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—TH—peripheral nervous system neoplasm	0.000249	0.00393	CbGpPWpGaD
Capecitabine—TYMS—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000243	0.00384	CbGpPWpGaD
Capecitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000239	0.00378	CbGpPWpGaD
Capecitabine—CDA—Metabolism—BCHE—peripheral nervous system neoplasm	0.000236	0.00373	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000231	0.00364	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000225	0.00356	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ENO2—peripheral nervous system neoplasm	0.000224	0.00353	CbGpPWpGaD
Capecitabine—CDA—Metabolism—TH—peripheral nervous system neoplasm	0.000222	0.00351	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000219	0.00346	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000206	0.00326	CbGpPWpGaD
Capecitabine—TYMS—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000205	0.00323	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GNAS—peripheral nervous system neoplasm	0.000204	0.00321	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ABCB1—peripheral nervous system neoplasm	0.0002	0.00315	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000199	0.00314	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BCHE—peripheral nervous system neoplasm	0.000189	0.00298	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNS—peripheral nervous system neoplasm	0.000189	0.00298	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GNAS—peripheral nervous system neoplasm	0.000181	0.00286	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NME1—peripheral nervous system neoplasm	0.000181	0.00286	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00018	0.00284	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000178	0.00281	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—TH—peripheral nervous system neoplasm	0.000178	0.0028	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—COX2—peripheral nervous system neoplasm	0.000174	0.00275	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000169	0.00267	CbGpPWpGaD
Capecitabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000184	CcSEcCtD
Capecitabine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000183	CcSEcCtD
Capecitabine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000183	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000168	0.000183	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000167	0.00264	CbGpPWpGaD
Capecitabine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000182	CcSEcCtD
Capecitabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000182	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000181	CcSEcCtD
Capecitabine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.000181	CcSEcCtD
Capecitabine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000166	0.000181	CcSEcCtD
Capecitabine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.00018	CcSEcCtD
Capecitabine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00018	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000165	0.000179	CcSEcCtD
Capecitabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000165	0.000179	CcSEcCtD
Capecitabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Capecitabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Capecitabine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000178	CcSEcCtD
Capecitabine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000178	CcSEcCtD
Capecitabine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000163	0.000178	CcSEcCtD
Capecitabine—Pain—Etoposide—peripheral nervous system neoplasm	0.000163	0.000178	CcSEcCtD
Capecitabine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000177	CcSEcCtD
Capecitabine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000177	CcSEcCtD
Capecitabine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000177	CcSEcCtD
Capecitabine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000177	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000176	CcSEcCtD
Capecitabine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000176	CcSEcCtD
Capecitabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000161	0.000175	CcSEcCtD
Capecitabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000174	CcSEcCtD
Capecitabine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000173	CcSEcCtD
Capecitabine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000173	CcSEcCtD
Capecitabine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000172	CcSEcCtD
Capecitabine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000172	CcSEcCtD
Capecitabine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000171	CcSEcCtD
Capecitabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000157	0.000171	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000171	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000157	0.000171	CcSEcCtD
Capecitabine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00017	CcSEcCtD
Capecitabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00017	CcSEcCtD
Capecitabine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000156	0.00017	CcSEcCtD
Capecitabine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000156	0.00017	CcSEcCtD
Capecitabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000169	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000155	0.00245	CbGpPWpGaD
Capecitabine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000169	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000169	CcSEcCtD
Capecitabine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000168	CcSEcCtD
Capecitabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000168	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000168	CcSEcCtD
Capecitabine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000153	0.000167	CcSEcCtD
Capecitabine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000167	CcSEcCtD
Capecitabine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000167	CcSEcCtD
Capecitabine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000166	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000166	CcSEcCtD
Capecitabine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000152	0.000165	CcSEcCtD
Capecitabine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000165	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000165	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000165	CcSEcCtD
Capecitabine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000164	CcSEcCtD
Capecitabine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000163	CcSEcCtD
Capecitabine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00015	0.000163	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.00015	0.00236	CbGpPWpGaD
Capecitabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000163	CcSEcCtD
Capecitabine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000163	CcSEcCtD
Capecitabine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000162	CcSEcCtD
Capecitabine—Rash—Vincristine—peripheral nervous system neoplasm	0.000148	0.000162	CcSEcCtD
Capecitabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000148	0.000162	CcSEcCtD
Capecitabine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Capecitabine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Capecitabine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Capecitabine—Headache—Vincristine—peripheral nervous system neoplasm	0.000148	0.000161	CcSEcCtD
Capecitabine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00016	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000159	CcSEcCtD
Capecitabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000158	CcSEcCtD
Capecitabine—TYMP—Metabolism—GNAS—peripheral nervous system neoplasm	0.000145	0.00229	CbGpPWpGaD
Capecitabine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000158	CcSEcCtD
Capecitabine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000158	CcSEcCtD
Capecitabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000155	CcSEcCtD
Capecitabine—TYMP—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000142	0.00225	CbGpPWpGaD
Capecitabine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000155	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000154	CcSEcCtD
Capecitabine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000153	CcSEcCtD
Capecitabine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000141	0.000153	CcSEcCtD
Capecitabine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000153	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000152	CcSEcCtD
Capecitabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00014	0.000152	CcSEcCtD
Capecitabine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000152	CcSEcCtD
Capecitabine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000152	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000152	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000152	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000152	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000151	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000151	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00015	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Capecitabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Capecitabine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Capecitabine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000148	CcSEcCtD
Capecitabine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000148	CcSEcCtD
Capecitabine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000147	CcSEcCtD
Capecitabine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000135	0.000147	CcSEcCtD
Capecitabine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000146	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000146	CcSEcCtD
Capecitabine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000145	CcSEcCtD
Capecitabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000144	CcSEcCtD
Capecitabine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000144	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000143	CcSEcCtD
Capecitabine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000143	CcSEcCtD
Capecitabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000143	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000143	CcSEcCtD
Capecitabine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000143	CcSEcCtD
Capecitabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000131	0.000142	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000142	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000141	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000141	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000141	CcSEcCtD
Capecitabine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000141	CcSEcCtD
Capecitabine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00014	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000128	0.00201	CbGpPWpGaD
Capecitabine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000138	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000138	CcSEcCtD
Capecitabine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Capecitabine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Capecitabine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000136	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000135	CcSEcCtD
Capecitabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000135	CcSEcCtD
Capecitabine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000134	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000134	CcSEcCtD
Capecitabine—TYMS—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000122	0.00193	CbGpPWpGaD
Capecitabine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000133	CcSEcCtD
Capecitabine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000132	CcSEcCtD
Capecitabine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000132	CcSEcCtD
Capecitabine—Rash—Etoposide—peripheral nervous system neoplasm	0.00012	0.000131	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00012	0.000131	CcSEcCtD
Capecitabine—Headache—Etoposide—peripheral nervous system neoplasm	0.000119	0.00013	CcSEcCtD
Capecitabine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.00013	CcSEcCtD
Capecitabine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000129	CcSEcCtD
Capecitabine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000128	CcSEcCtD
Capecitabine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000128	CcSEcCtD
Capecitabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000128	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000128	CcSEcCtD
Capecitabine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000127	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000126	CcSEcCtD
Capecitabine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000125	CcSEcCtD
Capecitabine—TYMS—Metabolism—ENO2—peripheral nervous system neoplasm	0.000114	0.00181	CbGpPWpGaD
Capecitabine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000125	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000124	CcSEcCtD
Capecitabine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000113	0.000123	CcSEcCtD
Capecitabine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000123	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000123	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000122	CcSEcCtD
Capecitabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000121	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000121	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000121	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000111	0.00176	CbGpPWpGaD
Capecitabine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000121	CcSEcCtD
Capecitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000111	0.00175	CbGpPWpGaD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000121	CcSEcCtD
Capecitabine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00012	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000119	CcSEcCtD
Capecitabine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000119	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000119	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000118	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000118	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000117	CcSEcCtD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000108	0.0017	CbGpPWpGaD
Capecitabine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000117	CcSEcCtD
Capecitabine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000116	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000116	CcSEcCtD
Capecitabine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000116	CcSEcCtD
Capecitabine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000115	CcSEcCtD
Capecitabine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000115	CcSEcCtD
Capecitabine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000114	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000114	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000114	CcSEcCtD
Capecitabine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000114	CcSEcCtD
Capecitabine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000113	CcSEcCtD
Capecitabine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000113	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000112	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000112	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000112	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000112	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000112	CcSEcCtD
Capecitabine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000111	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000111	CcSEcCtD
Capecitabine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00011	CcSEcCtD
Capecitabine—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.99e-05	0.000109	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000109	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	9.92e-05	0.00157	CbGpPWpGaD
Capecitabine—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000108	CcSEcCtD
Capecitabine—Infection—Doxorubicin—peripheral nervous system neoplasm	9.83e-05	0.000107	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000106	CcSEcCtD
Capecitabine—Shock—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000106	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000106	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000106	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.000105	CcSEcCtD
Capecitabine—TYMS—Metabolism—BCHE—peripheral nervous system neoplasm	9.67e-05	0.00153	CbGpPWpGaD
Capecitabine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000105	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000105	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.6e-05	0.000105	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000104	CcSEcCtD
Capecitabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000104	CcSEcCtD
Capecitabine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.43e-05	0.000103	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000103	CcSEcCtD
Capecitabine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000101	CcSEcCtD
Capecitabine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.000101	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000101	CcSEcCtD
Capecitabine—TYMS—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.22e-05	0.00146	CbGpPWpGaD
Capecitabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.22e-05	0.0001	CcSEcCtD
Capecitabine—Constipation—Epirubicin—peripheral nervous system neoplasm	9.14e-05	9.96e-05	CcSEcCtD
Capecitabine—Pain—Epirubicin—peripheral nervous system neoplasm	9.14e-05	9.96e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—TH—peripheral nervous system neoplasm	9.09e-05	0.00143	CbGpPWpGaD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	9.82e-05	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	9.75e-05	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	9.68e-05	CcSEcCtD
Capecitabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	9.61e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.81e-05	9.6e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.74e-05	9.52e-05	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	9.49e-05	CcSEcCtD
Capecitabine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	9.37e-05	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	9.3e-05	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.53e-05	9.29e-05	CcSEcCtD
Capecitabine—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.49e-05	9.25e-05	CcSEcCtD
Capecitabine—Pain—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	9.22e-05	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.46e-05	9.22e-05	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.45e-05	9.21e-05	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.45e-05	9.21e-05	CcSEcCtD
Capecitabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	8.88e-05	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	8.81e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.88e-05	8.58e-05	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	8.56e-05	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	8.52e-05	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	8.52e-05	CcSEcCtD
Capecitabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.67e-05	8.36e-05	CcSEcCtD
Capecitabine—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.56e-05	8.24e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.53e-05	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	7.52e-05	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GNAS—peripheral nervous system neoplasm	7.42e-05	0.00117	CbGpPWpGaD
Capecitabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.32e-05	7.97e-05	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	7.94e-05	CcSEcCtD
Capecitabine—TYMS—Metabolism—ABCB1—peripheral nervous system neoplasm	7.28e-05	0.00115	CbGpPWpGaD
Capecitabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	7.73e-05	CcSEcCtD
Capecitabine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.07e-05	7.7e-05	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7e-05	7.62e-05	CcSEcCtD
Capecitabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.8e-05	7.4e-05	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	7.37e-05	CcSEcCtD
Capecitabine—Rash—Epirubicin—peripheral nervous system neoplasm	6.74e-05	7.34e-05	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.74e-05	7.34e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—MYC—peripheral nervous system neoplasm	6.72e-05	0.00106	CbGpPWpGaD
Capecitabine—Headache—Epirubicin—peripheral nervous system neoplasm	6.7e-05	7.3e-05	CcSEcCtD
Capecitabine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	7.13e-05	CcSEcCtD
Capecitabine—Nausea—Epirubicin—peripheral nervous system neoplasm	6.35e-05	6.92e-05	CcSEcCtD
Capecitabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	6.85e-05	CcSEcCtD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.26e-05	0.000987	CbGpPWpGaD
Capecitabine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	6.79e-05	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.23e-05	6.79e-05	CcSEcCtD
Capecitabine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	6.75e-05	CcSEcCtD
Capecitabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	6.4e-05	CcSEcCtD
Capecitabine—TYMS—Cell Cycle—TP53—peripheral nervous system neoplasm	5.52e-05	0.000871	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—peripheral nervous system neoplasm	5.49e-05	0.000867	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	5.44e-05	0.000859	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	5.22e-05	0.000823	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	5.02e-05	0.000793	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—peripheral nervous system neoplasm	4.9e-05	0.000773	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—peripheral nervous system neoplasm	3.91e-05	0.000618	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	3.3e-05	0.00052	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.79e-05	0.00044	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.66e-05	0.000419	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.62e-05	0.000413	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	2.14e-05	0.000337	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	2.1e-05	0.000331	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—peripheral nervous system neoplasm	2e-05	0.000316	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	5.77e-06	9.11e-05	CbGpPWpGaD
